Zoledronate In the Prevention of Paget's Disease: Long Term Extension (ZiPP-LTE)
Sponsor: European Research Council
Listed as NCT03859895, this observational or N/A phase trial focuses on Paget Disease and remains ongoing. Sponsored by European Research Council, it has been updated 12 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Enrolling By Invitation
-
Mar 2025 — Feb 2026 [monthly]
Enrolling By Invitation
-
Sep 2024 — Mar 2025 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Dec 2023 — Jul 2024 [monthly]
Enrolling By Invitation
Status: Recruiting → Enrolling By Invitation
▶ Show 7 earlier versions
-
Apr 2022 — Dec 2023 [monthly]
Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Recruiting
-
May 2019 — Nov 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2019 — May 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- European Research Council
- University of Edinburgh
For direct contact, visit the study record on ClinicalTrials.gov .